Effect of Single-dose Azithromycin on Pneumococcal Carriage and Resistance: A Randomized Controlled Trial.

Publication Year: 2022

DOI:
10.1097/INF.0000000000003585

PMCID:
PMC9359759

PMID:
35944061

Journal Information

Full Title: Pediatr Infect Dis J

Abbreviation: Pediatr Infect Dis J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors have no conflicts of interest to disclose."

Evidence found in paper:

"The GAMIN study was supported by the Bill and Melinda Gates Foundation (OPP1187628). Azithromycin and matching placebo were donated by Pfizer, Inc (New York, NY). TD was supported in part by a Research to Prevent Blindness Career Development Award. The funders played no role in the design or conduct of the study, interpretation of data, or the decision to publish."

Evidence found in paper:

"This study was prospectively registered at clinicaltrials.gov (NCT03676751). Registered 19 September 2018."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025